Patent details

Basic Information

Publication number:

EP2118074

PCT Application Number:

PCT/CA/2007/000146

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP077105971

PCT Publication Number:

WO/2008/092231

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

French Title of Invention:

COMPOSÉS DESTINÉS À LA PRÉVENTION ET AU TRAITEMENT DE MALADIES CARDIOVASCULAIRES

German Title of Invention:

VERBINDUNGEN ZUR PRÄVENTION UND BEHANDLUNG VON HERZ-KREISLAUF-ERKRANKUNGEN

SPC Number:

Dates

Filing date:

01/02/2007

Grant date:

22/01/2014

EP Publication Date:

22/01/2014

PCT Publication Date:

07/08/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/11/2009

EP B1 Publication Date:

22/01/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

01/02/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/03/2015

 

 

Name:

RESVERLOGIX CORP.

Address:

300, 4820 RICHARD ROAD SW, CALGARY , AB T3E 6L1, Canada (CA)

History of Owners

From:

01/02/2007

To:

15/03/2015

Name:

RESVERLOGIX CORP.

Address:

202, 279 Midpark Way S.E., Calgary, Alberta T2X 1M2, Canada (CA)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

05/03/2014

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

HANSEN Henrik

Address:

Canada (CA)

Classification

Main IPC Class:

C07D 239/91;

Annual Fees

Annual Fee Due Date:

02/03/2026

Annual Fee Number:

20

Annual Fee Amount:

300 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/01/2025

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages